SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-16-009092
Filing Date
2016-04-11
Accepted
2016-04-11 08:37:00
Documents
4
Period of Report
2016-05-23
Effectiveness Date
2016-04-11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_041116.htm DEF 14A 749488
2 GRAPHIC logo.jpg GRAPHIC 6569
3 GRAPHIC proxycard_1.jpg GRAPHIC 206929
4 GRAPHIC proxycard_2.jpg GRAPHIC 124736
  Complete submission text file 0001171843-16-009092.txt   1216703
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 161563935
SIC: 2836 Biological Products, (No Diagnostic Substances)